101 related articles for article (PubMed ID: 28592208)
1. Is a polygenic predictor of antidepressant response a possibility?
Fabbri C
Pharmacogenomics; 2017 Jun; 18(8):749-752. PubMed ID: 28592208
[No Abstract] [Full Text] [Related]
2. Pharmacogenomics polygenic risk score for drug response prediction using PRS-PGx methods.
Zhai S; Zhang H; Mehrotra DV; Shen J
Nat Commun; 2022 Sep; 13(1):5278. PubMed ID: 36075892
[TBL] [Abstract][Full Text] [Related]
3. Clinical application of antidepressant pharmacogenetics: Considerations for the design of future studies.
Fabbri C; Serretti A
Neurosci Lett; 2020 May; 726():133651. PubMed ID: 29906483
[TBL] [Abstract][Full Text] [Related]
4. Interpreting Alzheimer disease polygenic scores.
Tan CH; Desikan RS
Ann Neurol; 2018 Mar; 83(3):443-445. PubMed ID: 29394507
[No Abstract] [Full Text] [Related]
5. The pharmacogenomics of selective serotonin reuptake inhibitors.
García-Marín LM; Rabinowitz JA; Ceja Z; Alcauter S; Medina-Rivera A; Rentería ME
Pharmacogenomics; 2022 Jul; 23(10):597-607. PubMed ID: 35673953
[TBL] [Abstract][Full Text] [Related]
6. Polygenic scores: Are they a public health hazard?
Baverstock K
Prog Biophys Mol Biol; 2019 Dec; 149():4-8. PubMed ID: 31398368
[TBL] [Abstract][Full Text] [Related]
7. Progress and prospects in pharmacogenetics of antidepressant drugs.
Fabbri C; Crisafulli C; Calabrò M; Spina E; Serretti A
Expert Opin Drug Metab Toxicol; 2016 Oct; 12(10):1157-68. PubMed ID: 27310483
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide association studies in pharmacogenomics of antidepressants.
Lin E; Lane HY
Pharmacogenomics; 2015; 16(5):555-66. PubMed ID: 25916525
[TBL] [Abstract][Full Text] [Related]
9. Depression and Pharmacogenetics.
Ampong DN
Arch Psychiatr Nurs; 2018 Feb; 32(1):71-74. PubMed ID: 29413077
[TBL] [Abstract][Full Text] [Related]
10. Therapy response prediction in major depressive disorder: current and novel genomic markers influencing pharmacokinetics and pharmacodynamics.
Shalimova A; Babasieva V; Chubarev VN; Tarasov VV; Schiöth HB; Mwinyi J
Pharmacogenomics; 2021 Jun; 22(8):485-503. PubMed ID: 34018822
[TBL] [Abstract][Full Text] [Related]
11. Polygenic risk score and heritability estimates reveals a genetic relationship between ASD and OCD.
Guo W; Samuels JF; Wang Y; Cao H; Ritter M; Nestadt PS; Krasnow J; Greenberg BD; Fyer AJ; McCracken JT; Geller DA; Murphy DL; Knowles JA; Grados MA; Riddle MA; Rasmussen SA; McLaughlin NC; Nurmi EL; Askland KD; Cullen BA; Piacentini J; Pauls DL; Bienvenu OJ; Stewart SE; Goes FS; Maher B; Pulver AE; Valle D; Mattheisen M; Qian J; Nestadt G; Shugart YY
Eur Neuropsychopharmacol; 2017 Jul; 27(7):657-666. PubMed ID: 28641744
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide analysis suggests the importance of vascular processes and neuroinflammation in late-life antidepressant response.
Marshe VS; Maciukiewicz M; Hauschild AC; Islam F; Qin L; Tiwari AK; Sibille E; Blumberger DM; Karp JF; Flint AJ; Turecki G; Lam RW; Milev RV; Frey BN; Rotzinger S; Foster JA; Kennedy SH; Kennedy JL; Mulsant BH; Reynolds CF; Lenze EJ; Müller DJ
Transl Psychiatry; 2021 Feb; 11(1):127. PubMed ID: 33589590
[TBL] [Abstract][Full Text] [Related]
13. Genetic overlap between antipsychotic response and susceptibility to schizophrenia.
Ikeda M; Yoshimura R; Hashimoto R; Kondo K; Saito T; Shimasaki A; Ohi K; Tochigi M; Kawamura Y; Nishida N; Miyagawa T; Sasaki T; Tokunaga K; Kasai K; Takeda M; Nakamura J; Ozaki N; Iwata N
J Clin Psychopharmacol; 2015 Feb; 35(1):85-8. PubMed ID: 25502484
[No Abstract] [Full Text] [Related]
14. Genome-wide Polygenic Burden of Rare Deleterious Variants in Sudden Unexpected Death in Epilepsy.
Leu C; Balestrini S; Maher B; Hernández-Hernández L; Gormley P; Hämäläinen E; Heggeli K; Schoeler N; Novy J; Willis J; Plagnol V; Ellis R; Reavey E; O'Regan M; Pickrell WO; Thomas RH; Chung SK; Delanty N; McMahon JM; Malone S; Sadleir LG; Berkovic SF; Nashef L; Zuberi SM; Rees MI; Cavalleri GL; Sander JW; Hughes E; Helen Cross J; Scheffer IE; Palotie A; Sisodiya SM
EBioMedicine; 2015 Sep; 2(9):1063-70. PubMed ID: 26501104
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide association meta-analyses identify novel genetic risk loci and polygenic phenotype associations for heroin, methamphetamine and alcohol dependences.
Chang SH; Sun Y; Wang F; Chang XW; Zhang YJ; Jia TY; Sun HQ; Yue WH; Wu P; Lu L; Shi J
Clin Transl Med; 2022 Jan; 12(1):e659. PubMed ID: 35075802
[No Abstract] [Full Text] [Related]
16. Genome-wide association studies (GWAS) in complex diseases: advantages and limitations.
Riancho JA
Reumatol Clin; 2012; 8(2):56-7. PubMed ID: 22089059
[No Abstract] [Full Text] [Related]
17. Local True Discovery Rate Weighted Polygenic Scores Using GWAS Summary Data.
Mak TS; Kwan JS; Campbell DD; Sham PC
Behav Genet; 2016 Jul; 46(4):573-82. PubMed ID: 26747043
[TBL] [Abstract][Full Text] [Related]
18. The pharmacogenetics of depression: enter the GWAS.
Malhotra AK
Am J Psychiatry; 2010 May; 167(5):493-5. PubMed ID: 20439394
[No Abstract] [Full Text] [Related]
19. GWAS to the people.
Nat Med; 2018 Oct; 24(10):1483. PubMed ID: 30297896
[No Abstract] [Full Text] [Related]
20. Developing and evaluating polygenic risk prediction models for stratified disease prevention.
Chatterjee N; Shi J; García-Closas M
Nat Rev Genet; 2016 Jul; 17(7):392-406. PubMed ID: 27140283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
